158 related articles for article (PubMed ID: 26814047)
1. Current status of the histopathological assessment, diagnosis, and reporting of colorectal neuroendocrine tumors: A Web survey from the Japanese Society for Cancer of Colon and Rectum.
Ikeda K; Kojima M; Saito N; Sakuyama N; Koushi K; Watanabe T; Sugihara K; Akimoto T; Ito M; Ochiai A
Pathol Int; 2016 Feb; 66(2):94-101. PubMed ID: 26814047
[TBL] [Abstract][Full Text] [Related]
2. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
[No Abstract] [Full Text] [Related]
3. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study.
Watanabe J; Suwa Y; Ota M; Ishibe A; Masui H; Nagahori K; Tsuura Y; Endo I
Dis Colon Rectum; 2016 Dec; 59(12):1160-1167. PubMed ID: 27824701
[TBL] [Abstract][Full Text] [Related]
5. Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?
Chen Y; Liu F; Meng Q; Ma S
World J Surg Oncol; 2017 Mar; 15(1):71. PubMed ID: 28351413
[TBL] [Abstract][Full Text] [Related]
6. Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors.
Matsukuma K; Olson KA; Gui D; Gandour-Edwards R; Li Y; Beckett L
Mod Pathol; 2017 Apr; 30(4):620-629. PubMed ID: 28084345
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment of colorectal neuroendocrine cell tumor].
Higuchi T; Sugihara K
Nihon Geka Gakkai Zasshi; 2008 May; 109(3):152-6. PubMed ID: 18536319
[TBL] [Abstract][Full Text] [Related]
8. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.
Lai M; Lü B; Xing X; Xu E; Ren G; Huang Q
Virchows Arch; 2006 Oct; 449(4):402-9. PubMed ID: 16955307
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 is a powerful tool for grading neuroendocrine tumors among Egyptian patients: a 10-year experience.
Salama A; Badawy O; Mokhtar N
J Cancer Res Clin Oncol; 2014 Apr; 140(4):653-61. PubMed ID: 24515911
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
[TBL] [Abstract][Full Text] [Related]
11. [Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].
Sun LM; Qiu XS; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):696-7. PubMed ID: 23302313
[No Abstract] [Full Text] [Related]
12. Neuroendocrine carcinomas of the colon and rectum.
Bernick PE; Klimstra DS; Shia J; Minsky B; Saltz L; Shi W; Thaler H; Guillem J; Paty P; Cohen AM; Wong WD
Dis Colon Rectum; 2004 Feb; 47(2):163-9. PubMed ID: 15043285
[TBL] [Abstract][Full Text] [Related]
13. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study].
Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454
[TBL] [Abstract][Full Text] [Related]
14. Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis.
Kim B; Kim HS; Moon KC
Diagn Pathol; 2019 Feb; 14(1):12. PubMed ID: 30732641
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
17. A simple and practical index predicting the prognoses of the patients with well-differentiated pancreatic neuroendocrine neoplasms.
Liu B; Kudo A; Kinowaki Y; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tanaka S; Akashi T; Tanabe M
J Gastroenterol; 2019 Sep; 54(9):819-828. PubMed ID: 30863885
[TBL] [Abstract][Full Text] [Related]
18. Primary Neuroendocrine Tumors of the Ureter: A Short Review.
Acosta AM; Kajdacsy-Balla A
Arch Pathol Lab Med; 2016 Jul; 140(7):714-7. PubMed ID: 27362572
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of metastasis‑related risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features.
Tang C; Gong L; Zou W; Zhang J; Zhou Y; Wu X; Lu F; Ouyang C; Liu X
Oncol Rep; 2016 Dec; 36(6):3343-3352. PubMed ID: 27748940
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
